Harvest One Cannabis Inc
Harvest One Announces Supply Agreement with Shoppers Drug Mart
Launch of Satipharm branded cannabis in Canada VANCOUVER, March 18, 2019 /CNW/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSXV:HVT; OTCQX:HRVOF), through it's wholly-owned subsidiary United Greeneries Ltd. ("United Greeneries") today announced that it has ... [Read]
Green Growth Brands LTD
Green Growth Brands Opens the First CBD Shop of 108 Planned in Simon’s U.S. Portfolio of Premier Retail Properties
Indiana and Kentucky mall openings brings Seventh Sense CBD shops total to five COLUMBUS, OH, March 18, 2019 /CNW/ - Green Growth Brands, Inc. (CSE:GGB) (OTCQB:GGBXF) (GGB or the Company) is pleased to announce the opening of two new CBD shops ... [Read]
Harvest One Cannabis Inc
Harvest One Provides an Update on Dream Water® on the Occasion of World Sleep Day 2019
TORONTO, March 15, 2019 /CNW/ - On the occasion of World Sleep Day, Harvest One Cannabis Inc. (TSXV:HVT, OTCQX:HRVOF – "Harvest One") provides an update on its wholly owned subsidiary Dream Water including a new supply agreement with ... [Read]
Cultivation & Retail
HEXO Stock Soars After Releasing Outstanding Q2 Results
HEXO stock is up over 12% in pre-market trading. Selling at present for $7.83 CAD on the TSX, the climb was almost inevitable. HEXO Corp's Q2 fiscal 2019 results were released a few hours ago, and ... [Read]
HEXO Corp
Hemp CBD Infused Product Market Projected to Triple by 2022
PALM BEACH, Florida, March 13, 2019 /CNW/ -- The passage of the U.S. Farm bill, which restored industrial hemp to nationwide legal production for the first time since World War II, has been generating a financial windfall ... [Read]
FSD Pharma Inc
FSD Pharma Announces New Leadership Appointment and Board Change
Dr. Sara May has been appointed as President of FV Pharma Vladimir Klacar departs from FSD Pharma's Board of Directors TORONTO, March 13, 2019 /CNW/ - FSD Pharma Inc. (CSE:HUGE) (OTCQB:FSDDF) (FRA: 0K9) ("FSD" or the "Company"), a licensed producer ... [Read]
InMed Pharmaceuticals Inc
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program
Transition to INM-755 Expected to Improve the Probability of Development and Regulatory Success Initiation of a Phase I Clinical Trial Remains On-track TSX:IN OTCQX:IMLFF VANCOUVER, March 13, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), ... [Read]
Cultivation & Retail
HEXO Stock Up +5% After Production Increase and Newstrike Acquisition
HEXO Corp. (TSX:HEXO) (NYSE:HEXO) is making a splash this week after announcing a few key victories that have investors impressed. HEXO stock is on an upswing moving into the tail-end of the week and is now on our ... [Read]
InMed Pharmaceuticals Inc
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019
VANCOUVER, March 12, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis platform technology for the manufacturing of pharmaceutical-grade cannabinoids as well as a R&D pipeline of medications targeting ... [Read]
Grown Rogue International Inc
Grown Rogue Bringing Proven Growth Model to Large Michigan Cannabis Market for 2019
MEDFORD, OR, March 12, 2019 /CNW/ - Grown Rogue International Inc. (CSE:GRIN |OTC:NVSIF) ("Grown Rogue" or the "Company"), a vertically-integrated, multi-state cannabis company, with licenses and operations in Oregon and California, is bringing its winning brand and business model which ... [Read]